Apexigen, Inc.
APGNDelisted Aug 23, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001814140
Apexigen, Inc. was delisted on Aug 23, 2023; its insiders filed their last Form 4 on Aug 25, 2023; 17 institutions reported holding it in 13F filings for Q2 2023, worth $1.37M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 17
- Q2 2023, −3 vs. previous quarter
- 13F value
- $1.37M
- Reported value at the end of Q2 2023
- Superinvestors holding
- 0
- At the end of Q2 2023
Superinvestors holding APGN, Q2 2023
No superinvestor reported holding APGN at the end of Q2 2023.
Latest insider trades
Open-market purchases and sales by Apexigen, Inc. insiders from Form 4, newest first.
No open-market purchases or sales by Apexigen, Inc. insiders are on file.
Top 10 13F holders, Q2 2023
The largest institutional positions in Apexigen, Inc. at the end of Q2 2023; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 1,894,551 | $814.3K | 0.26% | 00.0% | Unchanged |
| Fan Yu | 401,757 | $172.7K | 13.54% | 00.0% | Unchanged |
| Vanguard Group Inc | 256,935 | $110.4K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 213,833 | $91.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 178,760 | $76.8K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 54,300 | $23.3K | 0.00% | 00.0% | Unchanged |
| Mercer Global Advisors Inc | 43,626 | $19.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 44,150 | $19.0K | 0.00% | +29,338+198.1% | Added |
| Northern Trust Corp | 31,041 | $13.3K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 17,006 | $7.31K | 0.00% | −11,964−41.3% | Reduced |